Natural killer (NK) cells are important immune cells of the body. NK cells are not only related to anti-tumor, anti-viral infection, and immune regulation, but also participate in hypersensitivity and autoimmune diseases in some cases in which they identify target cells and killing mediators.
Cellular cytotoxicity is defined as the ability to kill other cells. It is an important effector mechanism of the immune system to fight viral infections and cancer. NK cells are one of the major mediators of cytotoxicity. NK cell-mediated cytotoxicity refers to the direct killing of viruses, tumor cells, and other foreign substances by NK cells.
Cytotoxicity mediated by NK cells plays an important role in the body's anti-viral infection and immune surveillance including innate immunity and adaptive immunity.
NK cells exert cytotoxicity through natural killing and ADCC (antibody-dependent cell-mediated cytotoxicity).
The recognition and killing of NK cells are mainly mediated through the interaction and balance between two receptors on the membrane surface, namely activating receptors (IL-15R, IL-2R, and IL-21R) and inhibitory receptors (KIR and CD94/NKG2A). Although NK cells do not express classical antigen receptors of the immunoglobulin gene family, such as the antibodies produced by B cells or the T cell receptor expressed by T cells, they are equipped with various receptors whose engagement allows them to discriminate between target and nontarget cells. Activation of NK is closely related to major histocompatibility complex (MHC) class I molecules secreted by target cells. The MHC class I molecules are recognized by NK cell inhibitory receptors and the ligation of these receptors inhibits the activation of NK cells. When the cells are infected by viruses or transformed, their MHC I molecules express low or abnormally. Low or abnormal expression of MHC I molecules removes the inhibition signal, leading to the activation of NK cells and then exerting a killing effect. Therefore, NK cells can avoid healthy cells expressing their own MHC class I molecules and cells with the low stress-induced state, that is, NK cells can selectively kill diseased target cells.
NK cells can also recognize cells coated with antibodies through the Fc gamma R III cell surface receptors, exerting ADCC action and secreting cytokines. Cytokines such as IFN-gamma, TNF, and IL-2 can effectively promote NK cells to express the low-affinity Fc receptor (Fc gamma R III) and enhance its ADCC effect. Under the action of the high concentration of IL-2, NK cells can be transformed into LAK, which greatly enhances its non-specific anti-tumor effect and is used for passive immunotherapy. After activation, NK cells induce target cell death through Ca2+-dependent granule exocytosis and release of FasL (Fas ligand) molecules and membrane-bound or secreted cytokines (e.g. TNF-α). This process is also known as ADCC.
|ARAF||ARAF Antibody||ARAF Protein||ARAF ELISA Kit|
|BID||BID Antibody||BID Protein||BID ELISA Kit|
|BRAF||BRAF Antibody||BRAF Protein||BRAF ELISA Kit|
|CASP3||CASP3 Antibody||CASP3 Protein||CASP3 ELISA Kit|
|CD244||CD244 Antibody||CD244 Protein||CD244 ELISA Kit|
|CD247||CD247 Antibody||CD247 Protein||CD247 ELISA Kit|
|CD48||CD48 Antibody||CD48 Protein||CD48 ELISA Kit|
|CSF2||CSF2 Antibody||CSF2 Protein||CSF2 ELISA Kit|
|FAS||FAS Antibody||FAS Protein||FAS ELISA Kit|
|FASLG||FASLG Antibody||FASLG Protein||FASLG ELISA Kit|
|FCER1G||FCER1G Antibody||FCER1G Protein||FCER1G ELISA Kit|
|FCGR3A||FCGR3A Antibody||FCGR3A Protein||FCGR3A ELISA Kit|
|FCGR3B||FCGR3B Antibody||FCGR3B Protein||FCGR3B ELISA Kit|
|FYN||FYN Antibody||FYN Protein||FYN ELISA Kit|
|GRB2||GRB2 Antibody||GRB2 Protein||GRB2 ELISA Kit|
|GZMB||GZMB Antibody||GZMB Protein||GZMB ELISA Kit|
|HCST||HCST Antibody||HCST Protein||HCST ELISA Kit|
|HLA-A||HLA-A Antibody||HLA-A Protein||HLA-A ELISA Kit|
|HLA-B||HLA-B Antibody||HLA-B Protein||HLA-B ELISA Kit|
|HLA-C||HLA-C Antibody||HLA-C Protein||HLA-C ELISA Kit|